IP Verse

Ipsen Pharma competitive analysis

Loading summary...

Latest oppositions filed by Ipsen Pharma

Explore patent oppositions filed by Ipsen Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3432916
Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
EP3436054
Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
EP2692350
Lyophilized Preparation Of Botulinum ToxinMEDY TOXFeb 2, 2018

Latest patents of Ipsen Pharma opposed by its competitors

Explore Ipsen Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2957278
May 17, 2017A Stable Composition Comprising Pthrp And Uses Thereof2
EP2249847
Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo Biloba1

Latest publications and patents of Ipsen Pharma New

Explore the latest publications and patents granted to Ipsen Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ipsen Pharma

EP2548568
Jan 10, 2018Melanocortin Receptor LigandsNo Opposition Filed Within Time Limit
EP2914280
Jan 3, 2018Somatostatin-Dopamine Chimeric AnalogsNo Opposition Filed Within Time Limit
EP2957278
May 17, 2017A Stable Composition Comprising Pthrp And Uses ThereofRevoked
EP2249847
Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo BilobaRevoked

Latest PTAB cases involving Ipsen Pharma

Discover the latest PTAB cases involving Ipsen Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ipsen Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IPSEN PHARMA33 - -
ALLERGAN11291333
DR WILLMAR SCHWABE25 - -
ISENBRUCK BOSL HORSCHLER1 - - -